Referências:
(1) Andıran N, Çelik N, Akça
H, Doğan G. Vitamin D deficiency in children and adolescents. J Clin Res Pediatr
Endocrinol. 2012 Mar;4(1):25-9.
(2) Gunta SS, Thadhani RI,
Mak RH. The effect of vitamin D status on risk factors for cardiovascular
disease. Nat Rev Nephrol. 2013 Apr 23.
(3) Torun E, Gönüllü E,
Ozgen IT, Cindemir E, Oktem F. Vitamin d deficiency and insufficiency in obese
children and adolescents and its relationship with insulin resistance. Int J
Endocrinol. 2013;2013:631845.
(4) Ben-Shoshan M. Vitamin d
deficiency/insufficiency and challenges in developing global vitamin d
fortification and supplementation policy in adults. Int J Vitam Nutr Res. 2012
Aug;82(4):237-59.
(5) Dr. Michael F. Holick .
The vtamin D solution. 2011.
(6) Manson JE, Bassuk SS,
Lee IM, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of
a large randomized controlled trial of vitamin Dand marine omega-3 fatty acid
supplements for the primary prevention of cancer and cardiovascular disease.
Contemp Clin Trials. 2012 Jan;33(1):159-71.
(7) Linus Pauling Institute
at Oregon State University - http://lpi.oregonstate.edu/
(8) Güttler N, Zheleva K,
Parahuleva M, Chasan R, Bilgin M, Neuhof C, Burgazli M, Niemann B, Erdogan A,
Böning A. Omega-3 Fatty acids and vitamin d in cardiology. Cardiol Res Pract.
2012;2012:729670.